Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Wong CI"'
Autor:
WONG, CI-HONG, 翁齊宏
105
Antibiotics should be added to boar semen extender to increase semen storage time and reduce pathogen proliferation. Although antibiotics easily cause bacterial resistance, a lack of them in boar semen results in bacterial proliferation, a d
Antibiotics should be added to boar semen extender to increase semen storage time and reduce pathogen proliferation. Although antibiotics easily cause bacterial resistance, a lack of them in boar semen results in bacterial proliferation, a d
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/36990575708796073275
Autor:
Wong, Ci-Shu.
Thesis (M.A.)--National Taiwan University Graduate Institute of Biochemistry and Molecularbiology.
Non-Latin script record. Includes bibliographical references.
Non-Latin script record. Includes bibliographical references.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wong CI, Koh TS, Soo R, Hartono S, Thng CH, McKeegan E, Yong WP, Chen CS, Lee SC, Wong J, Lim R, Sukri N, Lim SE, Ong AB, Steinberg J, Gupta N, Pradhan R, Humerickhouse R, Goh BC, Wong, Chiung-Ing
Publikováno v:
Journal of Clinical Oncology; 10/1/2009, Vol. 27 Issue 28, p4718-4726, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bourgeois W; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Paolino J; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Garland R; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Campbell K; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Alvarez-Calderon F; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Frazier AL; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., O'Neill AF; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Ilowite M; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass., Wong CI; From the Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Department of Pediatric Oncology, Boston, Mass.; Division of Pediatric Hematology-Oncology, University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio.; Division of Hematology-Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Publikováno v:
Pediatric quality & safety [Pediatr Qual Saf] 2024 Sep 25; Vol. 9 (5), pp. e771. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Autor:
Edwards JG; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Yan AP; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Yim R; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA., Oni M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Heeney MM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Johnson D; Boston Children's Hospital Program for Patient Safety and Quality, Boston, Massachusetts, USA., Wong CI; Division of Hematology/Oncology, Rainbow Babies and Children's Hospital and Seidman Cancer Center, University Hospitals, Cleveland, Ohio, USA., Ilowite M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Archer NM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31088. Date of Electronic Publication: 2024 May 29.